SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
+35.13%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$428M
AUM Growth
+$428M
(+15%)
Cap. Flow
-$30.5M
Cap. Flow
% of AUM
-7.11%
Top 10 Holdings %
Top 10 Hldgs %
66.43%
Holding
56
New
–
Increased
–
Reduced
6
Closed
1
Top Buys
1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$4.45M |
Top Sells
1 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$9.98M |
2 |
Immunocore
IMCR
|
$3.75M |
3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$3.62M |
4 |
HilleVax
HLVX
|
$2.61M |
5 |
Recursion Pharmaceuticals
RXRX
|
$2.18M |
Sector Composition
1 | Healthcare | 98.11% |
2 | Financials | 1.88% |